Evidence map›Paper›PMID 40238066›Full record

ArticleAnnals of surgical oncology2025

Correction: Economic Evaluation of Inguinal Versus Ilio-inguinal Lymphadenectomy for Patients with Stage III Metastatic Melanoma to Groin Lymph Nodes: Evidence from the EAGLE FM Randomized Trial.

Rashidul Alam Mahumud, Chi Kin Law, Daniel Ariza Ospino, Johannes H W de Wilt, Barbara L van Leeuwen, Chris Allan, Vinicius de Lima Vazquez, Rowan Pritchard Jones, Julie Howle, Barbara Peric and 2 more

Abstract readPublished Erratum
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Rashidul Alam MahumudNHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
Chi Kin LawNHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
Daniel Ariza OspinoMelanoma and Skin Cancer Trials Limited, Melbourne, VIC, Australia.
Johannes H W de WiltDepartment of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
Barbara L van LeeuwenDivision of Surgical Oncology, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Chris AllanFaculty of Medicine, Mater Clinical School, University of Queensland, Brisbane, QLD, Australia.
Vinicius de Lima VazquezMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Rowan Pritchard JonesDepartment of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Julie HowleSydney Medical School, The University of Sydney, Camperdown, NSW, Australia.
Barbara PericInstitute of Oncology Ljubljana, Zaloska 2, 1000, Ljubljana, Slovenia.
Andrew J SpillaneSydney Medical School, The University of Sydney, Camperdown, NSW, Australia.
Rachael Lisa MortonNHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia. rachael.morton@sydney.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40238066
PMCPMC12130059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.